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Genetic inhibition of autophagy induces degenerative changes inmammalian tissues that resemble
those associatedwith aging, andnormal andpathological aging are often associatedwith a reduced
autophagic potential. Pharmacological or genetic manipulations that increase life span in model
organisms often stimulate autophagy, and its inhibition compromises the longevity-promoting
effects of caloric restriction, Sirtuin 1 activation, inhibition of insulin/insulin growth factor signaling,
or the administration of rapamycin, resveratrol, or spermidine. Here, we discuss the probable cause
and effect relationship between perturbed autophagy and aging, as well as possible molecular
mechanisms that may mediate the anti-aging effects of autophagy.Introduction
Autophagy encompasses the different routes that cells use to
deliver cytoplasmic substrates to lysosomes for degradation.
These include macroautophagy, chaperone-mediated autoph-
agy, and microautophagy. Here, we focus on macroautophagy
(which we will hereafter refer to as autophagy), a process of
cellular self-cannibalism in which portions of the cytoplasm are
sequestered within double- or multimembraned vesicles (auto-
phagosomes) and then delivered to lysosomes for bulk degrada-
tion (Figure 1). The initial phases of macroautophagy consist of
the formation of a phagophore (also called isolation membrane),
the engulfment of cytoplasmic material by the phagophore, the
elongation of the phagophoremembrane, and fusion of its edges
to close the autophagosome. The outer membrane of the auto-
phagosome fuses with the lysosome to form the autolysosome
(also called autophagolysosome) in which the luminal material
including the internal membrane is degraded. The resulting
breakdown products are released through permeases and are
recycled in the cytosol (Ravikumar et al., 2010). Thus, autophagy
is the mechanism through which the nonnuclear (cytoplasmic)
parts of the cell can be renewed and through which cytoplasmic
macromolecules can be mobilized to generate energy-rich
compounds that can meet the bioenergetic demand of the cell
in conditions of dwindling external or internal resources.
Autophagy is a predominantly cytoprotective (rather than a
self-destructive) process (Kroemer and Levine, 2008). Accord-
ingly, autophagy can mediate protective effects in multiple
rodent models of organ damage affecting the liver (Zhang and
Cuervo, 2008), heart (Gottlieb and Mentzer, 2010), nervous
system (Ravikumar et al., 2010), and kidney (Jiang et al., 2010),
just to mention a few examples.682 Cell 146, September 2, 2011 ª2011 Elsevier Inc.Beyond its function in the adaptation of individual cells or
organs to changing conditions, autophagy has a prominent
role in determining the life span of many model organisms.
Reduced autophagy has been associated with accelerated
aging, whereas stimulation of autophagy might have potent
anti-aging effects (Madeo et al., 2010). This Review focuses on
several related questions. How can dysfunctional autophagy
lead to accelerated aging? In which cases does increased
autophagy counteract normal or pathological aging processes?
And which are the molecular mechanisms that link autophagy,
cytoprotection, longevity, and healthy aging?
Principal Functions of Autophagy
In yeast, autophagy is critical for survival during nutrient depriva-
tion, as it enables recycling of macromolecules to provide new
nutrients and energy. A key role for autophagy is as a degradative
pathway. Its substrates include aggregate-prone intracytoplas-
mic proteins that are associated with neurodegenerative dis-
eases such as mutant a-synuclein (which causes forms of
Parkinson’s disease), tau (implicated in Alzheimer’s disease),
and polyglutamine-expanded proteins like mutant huntingtin
(that causes Huntington’s disease). Indeed, when autophagy is
inhibited in otherwise normal mice, protein aggregates form in
the cytoplasm (Ravikumar et al., 2010).
Autophagy is also a critical regulator of organellar homeo-
stasis, particularly of mitochondria. Dysfunctional mitochondria
that have lost their membrane potential and are more likely to
release toxic apoptotic mediators and reactive oxygen species
are apparently selectively removed by autophagy relative to
‘‘healthy’’ mitochondria via phosphorylation reactions mediated
by the kinase PINK1 and subsequent ubiquitination of
Figure 1. Macroautophagy: An Overview
Irrespective of the origins of their double membrane,
autophagosomes engulf bulk portions of cytoplasm or
selective cargo, thus closing to become mature auto-
phagosomes. In this complex process, a series of au-
tophagy-related proteins and protein complexes are
sequentially involved. Autophagosomes eventually fuse
with lysosomes to form autolysosomes, in which the au-
tophagic cargo is degraded. The resulting biomolecules
are finally recycled back to the cytoplasm.mitochondrial membrane proteins by the E3 ligase Parkin. Auto-
phagy can also enhance degradation of various bacteria and
viruses and may play protective roles in numerous infectious
diseases (Ravikumar et al., 2010).
Autophagy Machinery
Traditionally, it has been believed that autophagosome forma-
tion starts at phagophore assembly sites (Figure 1). Phagophore
formation (autophagosome precursor/pre-autophagosomal
structures) requires the class III phosphoinositide 3-kinase
(PI3K) Vps34, which acts in a large macromolecular complex
that also contains Atg6 (also called Beclin 1), Atg14, and
Vps15 (p150). Other proteins involved in the early stages of
autophagy include Atg5, Atg12, Atg16, focal adhesion kinase
(FAK) family-interacting protein of 200 kD (FIP200), which inter-
acts with Atg1 (also called ULK1), and the mammalian ortholog
of Atg13 (Ravikumar et al., 2010).
The elongation of membranes that is thought to be critical for
autophagosome formation is associated with two ubiquitination-
like reactions. In the first of these, Atg12 is conjugated to Atg5
by Atg7, which is similar to an E1 ubiquitin-activating enzyme,
and Atg10, which is similar to an E2 ubiquitin-conjugating
enzyme. The Atg5-Atg12 conjugates interact noncovalently
with Atg16L1 and this complex associates with phagophores
but dissociates from completed autophagosomes. In the second
of the ubiquitin-like reactions, microtubule-associated protein 1
light chain 3 (MAP-LC3/Atg8/LC3) is conjugated to the lipid
phosphatidylethanolamine (PE) by Atg7 (E1-like) and Atg3 (E2-
like) to form LC3-II (Ravikumar et al., 2010).Multiple LC3-positive
autophagosomes form randomly in the cytoplasm, after which
they are trafficked along microtubules in a dynein-dependent
manner to lysosomes, which cluster close to the microtubule-
organizing center (MTOC) near the nucleus. Autophagosome-
lysosome fusion appears to be mediated by the SNARE proteins
VAMP8 and Vti1B (Furuta et al., 2010).CellSignals for Autophagosome Formation
The (mammalian) target of rapamycin (mTOR) is
a primordial negative regulator of autophagy in
organisms from yeast to man. mTOR is inhibited
under starvation conditions, and this contrib-
utes to starvation-induced autophagy via acti-
vation of mTOR targets Atg13, ULK1, and
ULK2. This inhibition can be mimicked by
mTOR inhibitory drugs like rapamycin (Raviku-
mar et al., 2010).
One of the important pathways regulating
mTOR is initiated when growth factors likeinsulin-like growth factor bind to insulin-like growth factor recep-
tors (IGF1R) (Figure 2). These receptors signal, via their tyrosine
kinase activities, to effectors like the insulin receptor substrates
(IRS1 and IRS2), which in turn activate Akt. Akt inhibits the
activity of the TSC1/TSC2 (proteins mutated in tuberous scle-
rosis) complex, a negative regulator of mTOR. In this way,
IGF1R signaling activates mTOR and inhibits autophagy, and
the converse occurs when nutrients are depleted.
mTOR activity can also be regulated by GTPases that
influence its lysosomal localization during extreme starvation.
Under these circumstances, mTOR complex 1 (which regulates
autophagy) dissociates from lysosomes where its direct activa-
tors reside (Sancak et al., 2010). Under milder starvation condi-
tions, mTOR activity is also inhibited, but the kinase remains
associated with lysosomes, which cluster around the MTOC.
This brings more lysosomes in the travel path of autophago-
somes and enhances autophagosome-lysosome fusion. When
nutrients are replenished, the lysosomes with the associated
mTOR move toward the plasma membrane. This is essential
for mTOR activation resulting in decreased autophagosome
formation (Korolchuk et al., 2011).
p53, which is commonly mutated in human cancers, can
positively and negatively regulate autophagy via the mTOR
pathway. Oncogenic or genotoxic stress stabilizes and activates
p53 and may stimulate autophagy by activating AMPK or by
upregulating the phosphatase and tensin homology (PTEN),
a negative regulator of Akt, and TSC1. On the other hand, genetic
or chemical inhibition of p53 also activates autophagy (Fleming
et al., 2011; Tasdemir et al., 2008).
Another pathway involved in starvation-induced autophagy is
mediated by inhibition of interactions between Beclin-1 (Atg6)
and the apoptosis-related proteins B cell lymphoma 2 (Bcl-2)
or basal-cell lymphoma-extra large (Bcl-XL). Starvation activates
c-Jun N-terminal kinase-1 (Jnk-1), which phosphorylates Bcl-2,
thereby disrupting the interaction between Beclin-1 and Bcl-2146, September 2, 2011 ª2011 Elsevier Inc. 683
Figure 2. The Regulation of Autophagy and Life
Span
The schematic represents a simplified overview of the
signaling pathways regulating autophagy and life span.
Green marks proteins/signaling circuitry that increase
longevity, whereas life span-reducing signals are marked
in red. Note that autophagy is only one of the conse-
quences of the depicted signal transduction pathways.and inducing autophagy. This mechanismmay also contribute to
autophagy upregulation by endoplasmic reticulum (ER) stress
(Ravikumar et al., 2010).
Autophagy can also be directly activated by adenosine mono-
phosphate-activated protein kinase (AMPK), which is induced
when nutrients are scarce or when AMP/ATP ratios rise, leading
to direct Ulk1 activation (Egan et al., 2011; Kim et al., 2011). In
addition, AMPK activation can also induce autophagy by inhibit-
ing mTOR.
Another mTOR-independent autophagy pathway is mediated
by the inhibition of inositol monophosphatase (IMPase), which
reduces free inositol and myoinositiol-1,4,5-triphosphate (IP3)
levels. Lithium, carbemazepine, and valproate—drugs that are
used to treat a range of neurological and psychiatric condi-
tions—induce autophagy via this pathway (Fleming et al.,
2011). IP3 may regulate autophagy negatively by binding to ER
IP3 receptors, which releases Ca2+ from stores in the ER, result-
ing in the activation of proteases of the calpain family that inhibit
autophagy by cleaving and activating Gsa, which produces
excess cAMP (Williams et al., 2008). However, other mecha-
nisms also appear to contribute. For example, lowering IP3
levels decreases ER Ca2+ influx into mitochondria and mildly
impairs mitochondrial respiration, leading to autophagy upregu-
lation via AMPK (Ca´rdenas et al., 2010). Alternatively, IP3 recep-
tors may also serve as negative regulators of autophagy by
binding Beclin-1 (Vicencio et al., 2009).
Premature Aging Due to Autophagy Inhibition
Multiple reports indicate that ATG proteins or other proteins
required for autophagy induction, such as Sirtuin 1, have
reduced expression in aged tissues and that autophagy dimin-
ishes with aging. This applies, for instance, to normal human
brain aging (in which Atg5, Atg7, and Beclin 1 are downregu-684 Cell 146, September 2, 2011 ª2011 Elsevier Inc.lated) (Lipinski et al., 2010), insulin resistance
and metabolic syndrome (in which Sirtuin1 is
downregulated) (de Kreutzenberg et al., 2010),
or osteoarthritis (in which ULK1, Beclin1, and
LC3 are downregulated) (Carame´s et al., 2010).
Likewise, IP3 receptor signaling is increased in
age-related neurodegenerative diseases such
as Alzheimer’s disease, as well as in other con-
ditions like cardiac hypertrophy, suggesting a
possible decrease in autophagy in these condi-
tions (Decuypere et al., 2011). Though merely
phenomenological and correlative, these find-
ings suggest that the enfeeblement of the
autophagic response may contribute to the
aging phenotype.Accordingly, an unbiased screen searching for chronological
aging factors in the yeast Saccharomyces cerevisiae led to the
identification of multiple short-lived mutants with autophagy
defects (including 10 ATG mutations among a total of 117
short-lived mutants) (Matecic et al., 2010). Loss-of-function
mutations in Atg1 (Unc-51), Atg7, Atg18, and Beclin 1 (Bec-1)
also decrease the life span of the nematode Caenorhabditis
elegans (To´th et al., 2008). Similarly, deficient expression in
Atg1, Atg8, and Sestrin1 (which is also required for basic autoph-
agy) reduces the life span of the fruit fly Drosophila melanogaster
(Lee et al., 2010a; Simonsen et al., 2008). This is linked to age-
associated pathologies, including triglyceride accumulation,
mitochondrial dysfunction, muscle degeneration, and cardiac
malfunction (Lee et al., 2010a).
In mice, the knockout of essential ATG proteins is lethal during
the early postnatal period because autophagy is indispensable
for mobilizing intracellular energy reserves during the transition
from intrauterine metabolism to weaning (Levine and Kroemer,
2008). The tissue-specific knockout of ATG genes has a less-
dramatic phenotype and instead precipitates the manifestation
of multiple age-associated stigmata, including the accumulation
of intracellular inclusion bodies containing ubiquitinylated pro-
teins, accumulation of lysosomes containing the aging pigment
lipofuscin, disorganized mitochondria, and oxidation of proteins
leading to their carbonylation, carboxymethylation, or nitrosyla-
tion (Table 1).
Few studies have tested whether one can affect age-related
phenotypes by correcting aging-associated defects in autoph-
agy. Zhang and Cuervo (2008) noted that the expression level
of LAMP2a dropped off with aging in the mouse liver and ex-
pressed an inducible hepatocyte-specific LAMP2a transgene to
correct levels of this protein to those seen in younger mice. Rein-
statement of normal LAMP2a levels averts the aging-associated
defect in chaperone-mediated autophagy (CMA) and macroau-
tophagy, and it decreases the abundance of oxidized proteins,
polyubiquitinated protein aggregates, and apoptotic cells within
the liver (Zhang and Cuervo, 2008). Liver autophagy is also
decreased in obesity and diabetes induced either by high-fat
diet or genetic deficiencies in leptin. Adenovirus-directed overex-
pression of Atg7 can correct this hepatic autophagic defect,
diminish ER stress, and counteract insulin resistance (Yang
et al., 2010). These results suggest that aging is associated
with insufficient autophagy, which can explain at least part of
the aging phenotype.
Increased Autophagy Delays Aging and Extends
Longevity
The first indication that increased autophagy may contribute to
longevity comes from the seminal observation that inhibition of
the insulin-like growth factor pathway causes autophagy in
C. elegans and that inhibition of autophagy bymutation of essen-
tial Atg genes prevents the gain of longevity (Mele´ndez et al.,
2003). Caloric restriction (CR), that is reduced food intake
without malnutrition, is the key anti-aging intervention that
extends life span in most animals so far tested, including in rhe-
sus monkeys, in which it reduces the incidence of diabetes,
cardiovascular disease, cancer, and brain atrophy (Colman
et al., 2009). Epidemiological studies suggest that CR is also
beneficial to human health. CR is the most physiological inducer
of autophagy (Levine and Kroemer, 2008), and inhibition of
autophagy prevents the anti-aging effects of CR in all species
investigated in this respect (Table 2).
Depending on the way that CR is imposed—by intermittent
feeding versus chronically reduced intake, its onset (juvenile
versus adult), or its intensity—CR induces autophagy through
the activation of either of two energy sensors, AMPK (Egan
et al., 2011; Kim et al., 2011) and Sirtuin 1 (SIRT1), which engage
in a positive forward loop ofmutual activation (Canto´ et al., 2010).
Moreover, CR can induce autophagy through the inhibition of
insulin/insulin-like growth (IGF) factor signaling, which also
results in TOR inhibition (Kenyon, 2010).
CR does not further increase life span when TOR signaling is
already reduced in yeast, worms, or flies, suggesting that
commonmechanismsmediate both of these anti-aging interven-
tions (Grandison et al., 2009). One such common mechanism
is autophagy because knockout or knockdown of atg genes
abolishes the life span-extending effects of rapamycin in all
species investigated (Bjedov et al., 2010) (Table 2). Inhibition of
TOR, either pharmacologically (with rapamycin) or genetically,
extends life span in yeast, C. elegans (Kenyon, 2010),
D. melanogaster (Bjedov et al., 2010), and mice (Harrison et al.,
2009). Although rapamycin potently induces autophagy, it may
impact on aging of mice by virtue of its capacity to suppress
inflammatory and autoimmune processes (Kapahi et al., 2010)
that negatively affect longevity. Moreover, TORC1 inhibition
has major effects on protein translation (Kapahi et al., 2010),
raising the question of whether mTOR inhibition enhances
longevity due to the induction of autophagy or whether this effect
also involves autophagy-unrelated effects.
The effects of mTOR inhibition on translation are explained
by the hypophosphorylation of its substrates S6K (which losesits kinase activity upon dephosphorylation) or that of 4E-BP
(which upon hypophosphorylation becomes active as a transla-
tional repressor to block the activity of the eIF4F complex).
Rapamycin fails to extend the life span of flies that overexpress
a constitutively active form of S6K (Bjedov et al., 2010). Impaired
expression of S6K extends the life span of C. elegans,
D. melanogaster, and mice (Hands et al., 2009; Selman et al.,
2009). S6K deletion leads to the activation of AMPK and fails
to increase longevity in AMPK-deficient nematodes (Selman
et al., 2009). Because AMPK is a potent activator of autophagy
(Ravikumar et al., 2010), it should be clarified whether S6K dele-
tion causes autophagy and whether autophagy may contribute
to the life span extension of S6K-deficient animals.
Inactivation of eIF4F by rapamycin reduces the translation of
transcripts with extensive secondary structure in their 50 untrans-
lated regions, and downregulation of various components of the
eIF4F cap-binding complex extends life span of C. elegans
(Hands et al., 2009; Syntichaki et al., 2007). In Drosophila,
4E-BP extends life span upon dietary restriction, presumably
because mitochondrial proteins involved in oxidative phosphor-
ylation that are encoded by nuclear genes are translated more
efficiently in a context of global decrease of translation, hence
improving mitochondrial function (Zid et al., 2009). Similarly,
reduced cytosolic protein synthesis suppresses the age-associ-
ated mitochondrial degeneration in yeast cells (Wang et al.,
2008). However, it has not been excluded yet that increased
autophagy resulting from 4E-BP overexpression (or perhaps
other methods to reduce translation) might increase the turnover
and hence improve the quality control of mitochondria. More-
over, it is formally possible that normal levels of autophagy
may be sufficient to guarantee for optimal selection of functional
mitochondria (and removal of dysfunctional ones) if the number
of organelles that are newly formed is reduced and/or their initial
quality is improved. Hence, the impact of invalidated autophagy
pathways on the longevity conferred by the activation of 4E-BP
or the inactivation of S6K or eIF4F should be studied in the future.
In C. elegans, the longevity-enhancing effect of inactivating
TOR or the S6K homolog rsks-1 (but not that of inactivating the
eIF4F component eIF4E/ife-2) requires pha-4 (Sheaffer et al.,
2008), which is the ortholog of the transcription factor FoxA.
PHA4 (FoxA) is also required for induction of autophagy by CR
(Hansen et al., 2008), suggesting yet another link between CR,
TOR, autophagy, and longevity. That said, the relationship
between CR and TOR is not completely linear, and rapamycin
can increase the longevity of weak insulin/Igf signaling (IIS)
pathway mutants and of flies with life span maximized by dietary
restriction, indicatingadditionalmechanisms (Bjedovet al., 2010).
Sirtuin 1 (SIRT1) and its orthologs (Sir2 in yeast and
Drosophila, sir-2.1 in C. elegans) reduce aging and prolong life
span upon their transgenic overexpression. CR extends life
span, in part, by increasing SIRT1 expression (or by activating
its enzymatic activity), and in yeast, worms, and flies, the lack
of Sir2 abrogates the effects of CR on life span. Resveratrol,
which directly or indirectly activates SIRT1, can prolong life
span, and this longevity-increasing effect is lost in yeast, worms,
and flies lacking Sir2. Similarly, mice that are deficient for SIRT1
do not show some of the beneficial effects of CR related to
longevity (Haigis and Sinclair, 2010). CR and resveratrol induceCell 146, September 2, 2011 ª2011 Elsevier Inc. 685
Table 1. Selected Aging-Related Phenotypes of Autophagy-Deficient Mice
Autophagy Deficiency and Genotype Phenotype Disease Relevance Reference
Heterozygous knockout of Beclin 1 Enhanced inflammation, steatohepatitis,
enhanced frequency of hepatocellular
carcinomas, lung adenocarcinomas,
and lymphomas in aging mice; enhanced
accumulation of intraneuronal amyloid ß
upon transgenic expression of human
amyloid precursor protein
Aging-related malignancies;
neurodegeneration
Mathew et al., 2009;
Pickford et al., 2008
Bcn1+/
Central nervous system-specific
knockout of Atg5 or Atg7
Progressive accumulation of
ubiquitinylated proteins as inclusion
bodies in neurons, followed by cortical
and cerebellar neuronal loss and
premature death
Neurodegeneration Komatsu et al., 2006;
Hara et al., 2006
Atg5F/F;Nestin-Cre or Atg7F/F;
Nestin-Cre
Purkinje cell-specific knockout
of Atg5 or Atg7
Axonal dystrophy and degeneration of
axon terminals; subsequent Purkinje
cell death and cerebellar ataxia
Komatsu et al., 2007
atg7flox/flox;Pcp2-Cre
Central nervous system-specific
knockout of FIP200
Accumulation of ubiquitinylated
proteins as inclusion bodies in
Purkinje neurons, cerebellar cell loss,
and cortical spongiosis
Liang et al., 2010
FIP200F/F;Nestin-Cre
General knockout of HDAC6 Intracellular ubiquitin+ aggregates
in the brain from 6 months of age
Neurodegeneration Lee et al., 2010b
HDAC6/
General knockout of PINK1 Selective mitochondrial defect
(complex I + II) in the striatum
Parkinson’s disease Gautier et al., 2008
PINK1/
Dynein mutations
(fly and mouse models)
Premature aggregate formation of
mutant huntingtin with increased
autophagosome formation and impaired
autophagosome-lysosome fusion
Huntington’s disease,
motor neuron diseases
Ravikumar et al., 2005
Liver- and spleen-specific
interferon-g-inducible
knockout of Atg7
Hepatomegaly, accumulation of
peroxisomes, deformed mitochondria
and ubiquitin-positive inclusions in
hepatocytes, hepatocyte death (increased
serum level of alkaline phosphatase,
aspartate aminotransferase, and alanine
aminotransferase); accumulation of
p62/STQM and consequent NRF2
activation
Hepatopathy Komatsu et al., 2010
Atg7flox/flox ;Mx1-Cre+
Hepatocyte-specific knockout
of Atg7
Lipid droplets containing triglycerides
and cholesterol accumulate in liver cells;
ER stress in hepatocytes and insulin
resistance
Metabolic syndrome,
steatohepatitis
Singh et al., 2009;
Yang et al., 2010
Atg7F/F;Alb-Cre
Skeleton-muscle specific
knockout of Atg7
Muscle atrophy and age-dependent
decrease in force; accumulation of
abnormal mitochondria, sarcoplasmic
reticulum distension, disorganization
of sarcomere; enhanced muscle loss
after fasting or denervation
Sarcopenia Masiero et al., 2009
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Table 1. Continued
Autophagy Deficiency and Genotype Phenotype Disease Relevance Reference
Atg7flox/flox ;Myosin light chain-Cre+
Islet ß cell-specific knockout
of Atg7
Accumulation of ubiquitinated protein
aggregates colocalized with p62,
mitochondrial swelling, endoplasmic
reticulum distension, and vacuolar
changes; degeneration of islets and
impaired glucose tolerance with reduced
insulin secretion; enhanced susceptibility
to high-fat diet-induced diabetes; this
phenotype can be improved by feeding
the antioxidant N-acetylcysteine
Insulin-dependent
diabetes
Jung et al., 2008;
Ebato et al., 2008;
Wu et al., 2009
Atg7flox/flox;RIP2-Cre+
Cardiomycyte-specific
constitutive knockout of Atg5
No cardiac phenotype in baseline
conditions but enhanced susceptibility
to acute pressure overload-induced
cardiac dysfunction and left ventricular
dilatation
Dilated cardiopathy Nakai et al., 2007
Atg5flox/flox;MLC2v-Cre+
Podocyte-spccific constitutive
knockout of Atg5
Spontaneous age-dependent late onset
glomerulosclerosis with accumulation
of oxidized and ubiquitinylated proteins,
compensatory proteasome activation,
lipofusin, damaged mitochondria,
ER stress, albuminuria, podocyte loss
Glomerulosclerosis Hartleben et al., 2010
Atg5flox/flox;Podocin-Cre+ Enhanced susceptibility to glomerulopathy
induced by injections of doxorubicin
or puromycin aminonucleosideautophagy in a Sir2-dependent fashion in yeast and C. elegans,
and the knockout or knockdown of atg genes abolishes the life
span-prolonging effect of CR, resveratrol, and Sir2 overexpres-
sion (Morselli et al., 2010). Thus, autophagy is required for the
life span-prolonging effect of SIRT1.
How SIRT1 triggers autophagy is not entirely clear. SIRT1 is an
NAD+-dependent deacetylase that acts both in the nucleus and
in the cytoplasm (Haigis and Sinclair, 2010). A cytoplasmic
variant of SIRT1 is as efficient as wild-type SIRT1 in inducing
autophagy, and resveratrol induces autophagy in enucleated
cells, suggesting that SIRT1 can induce autophagy through
nonnuclear effects (Morselli et al., 2011). Accordingly, SIRT1
deacetylates several atg gene products (ATG5, ATG7, and
ATG8/LC3) (Lee et al., 2008), and resveratrol induces the deace-
tylation of dozens of cytoplasmic proteins (Morselli et al., 2011).
SIRT1 also deacetylates the transcription factors p53, NF-kB,
HSF1, FOXO1, -3, -4, and PGC1a, all of which have widespread
effects in life span regulation and simultaneously influence
SIRT1 expression (Saunders and Verdin, 2009). In C. elegans,
life span extension by sir-2.1 requires the worm forkhead protein
DAF-16/FOXO (which is directly activated by sir-2.1) but may not
require an intact insulin signaling pathway (Wang and Tissen-
baum, 2006).
These results underscore the importance of DAF-16/FOXO for
determining life span. Indeed, genetic variations in one of the
human four FOXO orthologs, FOXO3A, have been linked to
longevity in multiple population studies (Kenyon, 2010). In nema-todes, the longevity of daf-2mutants (daf-2 encodes a hormone
receptor similar to the insulin and IGF-1 receptors) is abolished
by inactivation of daf-16 as well as by genetic inhibition of
autophagy. However, DAF-16/FOXO is not required for the
induction of autophagy by daf2 (Hansen et al., 2008). These
results have been interpreted to mean that autophagy frees up
new resources for the cell but that transcription factors like the
DAF-16/FOXO protein must channel this raw material into new
cell-protective proteins in order for life span to be increased
(Hansen et al., 2008) or, alternatively, that DAF-16/FOXO regu-
lates the expression of proteins that affect autophagy-indepen-
dent aspects of longevity.
Nonetheless, transgenic overexpression of DAF-16/FOXO
enhances autophagy in C. elegans (Jia et al., 2009), suggesting
that FOXO transcription factor may have a direct impact on
autophagy. There are also data in mammals suggesting that
FOXO3a can stimulate autophagy in response to starvation or
SIRT1 activation. In primarymouse renal cells, SIRT1 is activated
by CR and deacetylates FOXO3a, thereby favoring the transac-
tivation of bnip3, which codes for a potent autophagy inducer
(Kume et al., 2010). Similarly, FOXO3a inhibition or depletion
prevents autophagy induction by starvation in vivo in the mouse
muscle (Mammucari et al., 2007), confirming a strong link
between transcription factors of the FOXO family and autoph-
agy. It has not been investigated whether deacetylation (and
consequent inactivation?) of the p53 ortholog CEP1 is required
for longevity extension by sir-2.1 in C. elegans. However,Cell 146, September 2, 2011 ª2011 Elsevier Inc. 687
Table 2. Associations between Autophagy and Aging in Animals
Longevity-increasing/Anti-aging
Manipulations Phenotype Relationship to Autophagy Reference
daf-2 (Insulin/IGF-1 receptor)
loss-of-function mutant in
C. elegans
Enhanced autophagy
and life span
Abolishment of longevity phenotype
in animals with loss-of-function
mutations of bec-1 or upon atg-7
or atg-12 RNAi
Melendez et al., 2003
Dietary restriction mutant eat-2
(ad1113) in C. elegans.
Loss of longevity phenotype after
bec-1 and atg7 RNAi
Jia and Levine, 2007
Calcineurin (cnb-1) null mutant
(jh103) in C. elegans
Loss of longevity phenotype after
bec-1 and atg7 RNAi
Dwivedi et al., 2009
Administration of rapamycin
to C. elegans
Loss-of-function mutations of Atg1
or Atg7 abolish life span extension
Alvers et al., 2009
Administration of spermidine
to C. elegans
Loss of longevity phenotype after
bec-1 RNAi
Eisenberg et al., 2009
Administration of resveratrol
to C. elegans
Loss of longevity phenotype after
bec-1 RNAi
Morselli et al., 2010
Transgenic expression of Atg8a
in the brain of D. melanogaster
Counteracts the age-associated
loss of Atg8a expression; increased
life span (up to 56% in females),
reduced accumulation of insoluble
ubiquitinated proteins and
carbonylated proteins, increased
resistance against H202
Direct increase in autophagy within
neurons
Simonsen et al., 2008
Transgenic expression of FOXO
in the muscles of D. melanogaster
Improved proteostasis and muscle
function during aging; enhanced
longevity
Enhanced muscle autophagy;
knockdown of Atg7 enhances the
deposition of polyubiquitinated
protein aggregates
Demontis
and Perrimon, 2010
Administration of rapamycin
to Drosophila
Enhanced autophagy and life span Loss of longevity phenotype after
atg-5 RNAi
Bjedov et al., 2010
Administration of spermidine
to Drosophila
Enhanced autophagy and life span Loss-of-function mutations of
atg-7 abolish life span extension
Eisenberg et al., 2009
Increase of LAMP-2A abundance
by means of an inducible,
hepatocyte-specific transgene
in mice; LAMP2a-Alb-Tet-off
Reduced abundance of oxidized
proteins, polyubiquinated protein
aggregates, and TUNEL+ cells
Restoration of chaperone-mediated
autophagy and macroautophagy
in livers from aged animals
Zhang and Cuervo, 2008
Cardiomyocyte-specific expression
of a dominant-negative PI3Ka (p110a)
Enhanced autophagy, reduced
lipofuscin levels in the heart,
and increased longevity
Same as above Inuzuka et al., 2009
Knockin mutation of huntingtin,
causing the deletion of the
polyglutamine stretch (DQ); HttDQ/DQ
Increased longevity of mice;
the DQ Htt protein induces
autophagy in vitro
Same as above Zheng et al., 2010
Administration of rapamycin to mice Extension of maximum life span by
up to 14% in males and females
accompanied by mTOR inhibition
Same as above Harrison et al., 2009knockdown of CEP1 is sufficient to induce massive autophagy in
adult nematodes (Tasdemir et al., 2008) and to increase their life
span. Both of these effects are lost upon simultaneous knock-
down of atg genes (Tavernarakis et al., 2008).
In yeast, sir2p catalyzes histone H4 lysine 16 deacetylation.
An H4 K16Q mutation (which mimics deacetylation) suffices to
increase life span (Dang et al., 2009). Spermidine, which acts as
a histone acetylase inhibitor, reduces histone acetylation while
it upregulates the expression of atg genes, induces autophagy,
and extends longevity. The spermidine-induced increase in
longevity is lost in yeast, nematodes, and flies when atg genes688 Cell 146, September 2, 2011 ª2011 Elsevier Inc.are knocked out or knocked down (Eisenberg et al., 2009) yet is
not affected by the depletion of SIRT1 orthologs (Morselli et al.,
2011). Thus, enzymes with opposing functions on protein
acetylation, the deacetylase SIRT1 (and its orthologs), and a
range of histone acetylases increase autophagy-dependent
longevity when they are activated or inhibited, respectively.
Although it remains to be determinedwhich acetylation reactions
are the most relevant for the regulation of autophagy, it is note-
worthy that both resveratrol and spermidine stimulate overlap-
ping deacetylation reactions of cytoplasmic proteins (Morselli
et al., 2011).
Figure 3. Cell-Autonomous Anti-Aging Effects of
Autophagy
Autophagy may increase organismal fitness by inhibiting
cell death, reducing oncogenic transformation, or in-
creasing hormesis, both in quiescent and dividing cells
(left). In addition, autophagy may contribute to life span
extension through distinct mechanisms in postmitotic
(middle) and proliferating cells (right). HCS, hematopoietic
stem cell.As mentioned earlier, Huntington’s disease (HD) is caused
by a polyglutamine expansion in the huntingtin gene. Normal
mice have seven glutamines in this gene. Mice that are homo-
zygous for an artificial mutation in huntingtin (htt) from which
the polyglutamine tract has been completely removed (DQ)
demonstrate an extension in life span that is associated with
an increased level of autophagy (Zheng et al., 2010). Although
DQ htt induces autophagosome formation in an mTOR-inde-
pendent manner and this is not seen with the wild-type protein
(Zheng et al., 2010), it is possible that this mutant protein may
have other functions that contribute to the longevity of these
mice.
Altogether, accumulating yet fragmentary evidence indicates
that genetic or pharmacological manipulations that result in an
increase in longevity stimulate autophagy and that autophagy
is often, if not always, required for mediating the increase in life
expectancy.
Anti-Aging Effects of Autophagy in Postmitotic Cells
Autophagy plays a major role in protein homeostasis (proteasta-
sis) and organelle turnover. This role is particularly important in
nonproliferating cells because there is no cell division-mediated
‘‘dilution’’ of intracellular debris. Moreover, the anti-aging effects
of cytoprotection are particularly relevant for cells that are not (or
are poorly) replaced from stem cell niches (Figure 3).
Reduced Accumulation of Toxic Protein Aggregates
Intracellular protein misfolding and aggregation are the cardinal
features of many neurodegenerative diseases called proteinopa-
thies. These include Alzheimer’s disease, Parkinson’s disease,
tauopathies, and polyglutamine expansion diseases such as
HD. A number of experimental autophagy inducers, including
rapamycin, rapalogs, valproate, and lithium, can attenuate the
accumulation of mutated huntingtin protein and cell death inCellHD models (Ravikumar et al., 2010). Rapamy-
cin-stimulated autophagy may be instrumental
for the treatment of other intracellular proteino-
pathies, including those induced by mutant
and wild-type Tau (Ravikumar et al., 2010). Inhi-
bition of TOR by transgenic overexpression of
TSC1 and TSC2 also stimulates the clearance
of a human polyglutamine-expanded huntingtin
protein in vivo in photoreceptor neurons from
Drosophila, and a similar effect can be obtained
by overexpressing ATG1 (Wang et al., 2009).
Overexpression of TSC1 and TSC2 can avoid
the accumulation of cytosolic rhodopsin-
arresting complexes that result from the neuro-degeneration-inducing mutation of the phosphilase C gene
norpA (Wang et al., 2009), further supporting the notion that
autophagy can attenuate proteotoxicity.
Misfolded, aggregated, and ubiquitinylated proteins also
accumulate in nondividing cells, in particular, neurons of patients
during normal aging. However, it has not been formally demon-
strated that such protein aggregates are causally involved in
the aging process (instead of merely constituting a sign of aging)
and whether the anti-aging effects of autophagy may be ex-
plained by (rather than correlated with) the removal of such
inclusion bodies.
Improved Function of Mitochondria
Reportedly, mitochondrial fission can occur in an asymmetric
fashion, yielding one functional mitochondrion (that undergoes
successive rounds of fusion and fission) and one dysfunctional
one with a low membrane potential (DJm) that is targeted for
autophagic destruction (Twig et al., 2008). This mechanism
may contribute to autophagy-dependent mitochondrial quality
control. One prominent hypothesis of aging postulates an
accumulating mitochondrial damage leading to progressive
mitochondrial uncoupling with a consequent bioenergetic insuf-
ficiency and increased production of reactive oxygen species
(ROS) (Vijg and Campisi, 2008). As a common leitmotif, autoph-
agy inhibition results in deteriorated mitochondrial function in
nonmammalian model organisms and in mice. For instance, iso-
lated mitochondria from ATG-deficient postmitotic cells (e.g., in
skeletal muscles lacking expression of Atg7) exhibit a defective
oxidative phosphorylation tied to a switch of cellular metabolism
from respiration to glycolysis (Wu et al., 2009). Similarly, mito-
chondria from the striatum of PINK1 knockout mice are deficient
in complexes I and II (Gautier et al., 2008).
These examples illustrate the concept that the deficient
quality control of dysfunctional mitochondria may lead to their146, September 2, 2011 ª2011 Elsevier Inc. 689
pathogenic accumulation and that autophagy is responsible for
this quality control.
Reduced Cell Death and Improved Hormesis
Autophagy is a potent mechanism that reduces unwarranted
apoptotic or necrotic death of postmitotic cells. The induction
of autophagy is coupled to the liberation of Bcl-2 from the Beclin
1 complex, as well as that of FLIP from Atg3, potentially allowing
Bcl-2 and FLIP to become available to acutely block the intrinsic
and extrinsic pathways of apoptosis, respectively (Lee et al.,
2009; Pattingre et al., 2005). It remains to be determined to
what extent this putative mechanism might tie autophagy induc-
tion to acute cytoprotection.
Beyond its involvement in organellar quality control and the
removal of potential proteotoxins, autophagy plays an essential
role in the recovery of acutely injured cells with damaged mito-
chondria that otherwise would undergo apoptosis or necrosis
(Colell et al., 2007). Mitochondrial membrane permeabilization
(MMP) is (one of) the rate-limiting steps of cell death, and the
threshold beyond which MMP affecting a variable portion of
mitochondria kills cells is likewise determined by the autophagic
removal of permeabilized organelles (Kroemer et al., 2007). If
the most damaged mitochondria are selectively removed by
autophagy, the remaining mitochondria will likely have a higher
threshold for MMP, greater resistance to cytochrome c release,
and diminished ROS production.
Through this and related mechanisms, autophagy might
participate in hormesis, the phenomenon whereby cells, organs,
and organisms resist usually lethal conditions after they have
been exposed to a sublethal damage. One of the best-explored
examples of hormesis is ischemic preconditioning, the exposure
of the brain or heart to short episodes of ischemia that renders
these organs (relatively) resistant against subsequent stroke or
infarction, respectively. Autophagy has been shown to partici-
pate in the beneficial effects of preconditioning (Gottlieb and
Mentzer, 2010; Sheng et al., 2010). If hormesis determined the
pace of aging and death, as has been postulated (Le Bourg,
2009), and if autophagy were one of the effector mechanisms
of hormesis, for instance as a cleansing mechanism of damaged
organelles (Ristow and Zarse, 2010), then improved hormesis
might constitute one of the links between autophagy and
longevity.
Anti-Aging Effects of Autophagy in Proliferating Cells
In proliferating cells, autophagy not onlymediates cytoprotective
effects as those evoked above for postmitotic cells, but probably
also plays a major role in the avoidance of malignant transforma-
tion, as well as possibly in the maintenance of stem cell charac-
teristics (Figure 3).
Avoidance of Stem Cell Attrition
Progressive numerical or functional decline of tissue stem cells
may contribute to the aging phenotype. In old mice, rapamycin
increases life span (Harrison et al., 2009) and simultaneously
restores the self-renewal of hematopoietic stem cells (HSCs),
thus improving the function of the immune system (Chen et al.,
2009). Similarly, rapamycin can reverse the stem cell loss in
hair follicles that overexpress Wnt1 under the control of an in-
ducible promoter, as well as the consequent alopecia (Castilho
et al., 2009). Conversely, mTOR activation through conditional690 Cell 146, September 2, 2011 ª2011 Elsevier Inc.deletion of Tsc1 in the HSCs of young mice mimics the pheno-
type of HSCs from aged mice, leading to a relative decrease in
lymphopoiesis, an impaired capacity to reconstitute the hemato-
poietic system, as well as an increased expression of the CDK
inhibitors p16(Ink4a), p19(Arf), and p21(Cip1), which are potential
markers of cellular senescence (Chen et al., 2009). Though other
mTOR-related functions may contribute, at least part of this
phenotype may be mediated by deficient autophagy because
atg7 knockout leads to a severe attrition of the hematopoietic
stem cell and progenitor cell compartments (Mortensen et al.,
2011).
Similarly, inactivation of the tumor suppressor PTEN elicits
a senescence response that is different than the oncogene-
elicited DNA damage-dependent program and has been termed
PTEN loss-induced cellular senescence (PICS). PICS depends
on the activation or mTOR and can be potentiated by inhibition
of MDM2, which leads to an increase in p53 expression (Alimonti
et al., 2010) and can be expected to inhibit autophagy (Tasdemir
et al., 2008).
Rapamycin can avoid the permanent cell-cycle arrest (senes-
cence) that is artificially induced by inducible p21 expression
without affecting the acute block in cell-cycle advancement
(Blagosklonny, 2009). Thus, mTOR is likely to restrain prolifera-
tive potential (competence) and to mediate stem cell attrition
through senescence, an effect that can be suppressed by rapa-
mycin. Whether this effect of TORC1 is mediated by autophagy
or alternative rapamycin-elicited effects awaits urgent clarifica-
tion, and thus far no studies have addressed the importance of
autophagy for the maintenance of stem cell characteristics.
Reduced Oncogenic Transformation
Several oncogenes (for instance, activated Akt1, PI3K, and anti-
apoptotic proteins from the Bcl-2 family) suppress autophagy. In
addition, multiple tumor suppressor proteins (such as BH3-only
proteins, death-associated protein kinase-1 [DAPK1], PTEN,
tuberous sclerosis complex 1 and 2 [TSC1 and TSC2], and
LKB1/STK11) stimulate autophagy, meaning that their loss
reduces autophagy. Beclin-1, which is required for autophagy
induction, acts as a haploinsufficient tumor suppressor protein,
and other essential autophagy mediators (such as Atg4c,
AMBRA1, UVRAG, and Bif-1) are also bona fide oncosuppres-
sors because their genetic invalidation increases the frequency
of tumors in mice (Maiuri et al., 2009).
Autophagy can suppress oncogenesis through cell-autono-
mous effects such as improved quality control of mitochondria,
ameliorated genetic instability, and/or the autophagic removal
of the potentially oncogenic protein p62/SQTM1 (Mathew
et al., 2009). According to yet-to-be confirmed reports, auto-
phagy is upregulated during and partially required for onco-
gene-(H-rasV12)-induced senescence (Young et al., 2009) and
apoptosis (Elgendy et al., 2011), suggesting that autophagy
can contribute to tumor suppression at this level.
Cell-Nonautonomous Anti-Aging Effects of Autophagy
Beyond its action on proliferating or postmitotic cells, autophagy
may also mediate anti-aging effects by cell-nonautonomous
effects, including the defense against infectious microorgan-
isms, innate immune and inflammatory responses, and neuroen-
docrine regulation (Figure 4).
Figure 4. Systemic Anti-Aging Effects of Autophagy
Beyond its cell-autonomous action, autophagy can reduce age-related dysfunctions through systemic effects. Autophagy may contribute to the clearance of
intracellular pathogens and the function of antigen-presenting cells (left), reduce inflammation by several mechanisms (middle), or improve the function of
neuroendocrine circuits (right).Improved Innate Immune and Reduced Inflammatory
Responses
Themolecules and processes involved in autophagy play amajor
role in the control of intracellular microorganisms by ‘‘xenoph-
agy,’’ the cell-autonomous response against pathogen invasion
(Levine et al., 2011). Autophagy within dying antigen donor cells
can improve the cross-presentation of dead-cell antigens by
dendritic cells, perhaps because autophagosomes ferry anti-
gens to dendritic cells via an as yet unknown mechanism (Li
et al., 2008) or because higher amounts of type I interferon are
induced (Uhl et al., 2009). Moreover, in dendritic cells, autophagy
induction improves antigen presentation (Jagannath et al., 2009),
and several major immune effectors, including T lymphocytes,
rely on autophagy for the maintenance of their function (Levine
et al., 2011).
Autophagy can mitigate inflammatory reactions through
several mechanisms. Autophagy in dying cells is required for
optimal macrophage-mediated clearing of apoptotic corpses,
thus reducing inflammatory reactions (Levine and Kroemer,
2008). As cells succumb to apoptosis, autophagy is often
induced until the ultimate state of the apoptotic process that is
usually accompanied by caspase activation. Autophagy is
essential for the maintenance of intracellular ATP levels, which
in turn are required for the secretion of the ‘‘find-me’’ signal
lysophosphatidylcholine by, as well as the efficient exposure of
the ‘‘eat-me’’ signal phosphatidylserine on, dying cells. This
explains how insufficient autophagy can stimulate inflammatory
responses secondary to insufficient clearance of dead cells
(Orvedahl et al., 2007). Moreover, disabled autophagy provokes
the accumulation of p62/STQM1, which can activate the proin-
flammatory transcription factor NF-kB and the stress-responsive
transcription factor NRF2, thereby favoring inflammation and
tissue injury (Levine et al., 2011).
Autophagy can inhibit proinflammatory signaling via RIG-I-like
receptors, via direct conjugation of the receptors with Atg12-
Atg5 complexes, and through elimination of dysfunctional
mitochondria (Saitoh and Akira, 2010). Autophagy can also in-
hibit the activation of the NLRP3 inflammasome, the caspase-1activation complex required for the production of interleukin-
1b, by removing permeabilizing or ROS-producing mitochondria
(Nakahira et al., 2011; Zhou et al., 2011). Because neurodegen-
erative processes and pathological aging in general are fre-
quently accompanied by chronic inflammation, these anti-
inflammatory effects of autophagy may mediate additional
health benefits.
Altogether, the available data suggest that autophagy may
contribute to improving the efficacy of pathogen recognition by
immune effectors while reducing inflammatory reactions.
Neuroendocrine Parameters
The absence or presence of autophagy does not only affect
cellular physiology but likely can affect intercellular communica-
tion and hence affect aging-relevant processes in a noncell-
autonomous manner.
Beyond the fact that the function of endocrine cells, including
insulin-producing b cells, depends on autophagy (Wu et al.,
2009), deficient autophagy can also compromise the hormonal
response of tissues. Thus, age-associated defects in autophagy
might be implicated in type-2 diabetes, in which peripheral
tissues fail to respond to insulin. Thus, hepatic suppression of
the Atg7 gene results in ER stress and insulin resistance (Yang
et al., 2010). Overexpression of FOXO or its target 4E-BP in the
muscles of flies abolishes the age-associated decline in autoph-
agy and increases longevity while it reduces food intake and
insulin release from neurosecretory cells (Demontis and Perri-
mon, 2010), suggesting that maintenance of a normal autophagy
level in one organ may positively affect whole-body metabolism.
Induction of autophagy in Drosophila neurons (by overex-
pressing of an ATG8 transgene under the control of a neuron-
specific promoter) is sufficient to increase life span (Simonsen
et al., 2008). Similarly, overexpression of dSIR2 in neurons is
sufficient to increase the longevity in flies as much as the expres-
sion of dSIR2 under the control of an ubiquitous promoter
(Rogina andHelfand, 2004). This suggests that autophagy induc-
tion in specific neuronal populations may be sufficient to reduce
pathological aging. How this effect is achieved is not known, as
whether the manipulation of autophagy in neurons might affectCell 146, September 2, 2011 ª2011 Elsevier Inc. 691
autophagy in peripheral tissues has not been investigated.
However, in C. elegans, in daf-16/daf-2 double mutants, re-
expression of daf-16 in only one tissue (such as neurons or the
intestinal/adipose tissue) can extend the life span of the whole
animal (Murphy et al., 2007), presumably through feedback regu-
lation of insulin gene expression in other tissues.
Concluding Remarks
As outlined in this Review, the level of macroautophagy may play
a major role in determining health span and life span, although
two major and presently near-unresolvable caveats apply. First,
autophagy is not simply one uniform bulk degradation process
mediated by a single set of stimuli, as it may also involve the
selective removal of organelles, such as dysfunctional (mito-
chondria) and various infectious agents using additional
machinery and signals. This raises the potential challenge of
identifying specific pathways and substrates of autophagy with
anti-aging properties. Second, all pharmacological and genetic
manipulations of autophagy have off-target effects. Thus, even
the products of Atg genes have multiple functions outside of
the autophagic pathway, meaning that their overexpression or
ablation may influence the aging process through autophagy-
unrelated effects that must be studied in the future. Notwith-
standing these limitations, it is possible that the aging process
involves one or several vicious cycles that cause a progressive
deterioration of the autophagic system. Thus, at the cellular level,
insufficient autophagy compromises the degradation of ubiqui-
tin-proteasome pathway substrates due to the accumulation of
p62/SQSTM, resulting in higher levels of short-lived regulatory
proteins like p53 (Korolchuk et al., 2009), which in turn can inhibit
autophagy (Tasdemir et al., 2008) and induce cellular senes-
cence. Similarly, defective autophagy in the brain may stimulate
a systemic breakdown in neuroendocrine homeostasis that
accelerates the physiological and neurological decline. Defec-
tive autophagy may also favor the accumulation of lipofuscin
and lipid droplets, which in turn can inhibit autophagy (Singh
et al., 2009).
We acknowledge that much of the data supporting the anti-
aging effect of autophagy are from model organisms in which
the causes of death/longevity may differ from what impacts
human life span and health span. Ideally, one would like to be
able to test the effects of possible genetic or environmental
influences regulating autophagy with differences in human life
span in carefully designed epidemiological studies. One current
limitation in this context is the lack of suitable assays for
measuring autophagic flux in living humans (Mizushima et al.,
2010). However, it is likely that the physiological processes asso-
ciated with longevity of model organisms may protect against
diseases that afflict people. Indeed, it is worth noting that major
causes of death in developed countries, such as heart disease,
dementias, and cancers, may be enhanced by autophagy
inhibition and hence perhaps attenuated by autophagy upregu-
lation. As discussed here, even interventions aimed at stimu-
lating autophagy at a relatively mature age may have beneficial
effects on aging in mice. Thus, rapamycin treatment of middle-
aged mice (starting at 600 days) still can extend their life span
(Harrison et al., 2009), and a 3 month period of caloric restriction
can improve verbal memory in healthy aged humans (Witte et al.,692 Cell 146, September 2, 2011 ª2011 Elsevier Inc.2009), suggesting that pro-autophagic strategies may reduce
the time-dependent deterioration and even provide a transient
rejuvenation if applied to the healthy elderly.
It is then the question of what the optimal strategy would be to
improve healthy aging by enhancing autophagy without delete-
rious side effects. Intermittent fasting, for instance by alternating
days of starvation with days of ad libidum feeding, can increase
the life span of rodents as much as chronic caloric restriction
without a concomitantmajor decrease in bodymass—ameasure
that may avoid the negative effects of caloric restriction on bone
density and consequent pathological fractures (Mattson and
Wan, 2005). Moreover, it is tempting to speculate, though it
remains to be demonstrated, that a diet enriched in natural
pro-autophagic components including spermidine and polyphe-
nols (such as resveratrol or curcumin) might promote good
health and postpone our inevitable fate.
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